Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy.
Cancer theranostics
Chemodynamic therapy
Fenton-like reaction
Lyotropic liquid crystals
Optical imaging
Journal
Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
15
01
2020
revised:
09
06
2020
accepted:
11
06
2020
pubmed:
21
6
2020
medline:
15
5
2021
entrez:
21
6
2020
Statut:
ppublish
Résumé
Herein, we report the development of theranostic lyotropic liquid crystalline nanostructures (LCN's) loaded with unique MnO nanoparticles (MNPs) for selective cancer imaging and therapy. MNPs serves as a fluorescent agent as well as a source of manganese (Mn
Identifiants
pubmed: 32562804
pii: S1742-7061(20)30353-6
doi: 10.1016/j.actbio.2020.06.023
pii:
doi:
Substances chimiques
Hydrogen Peroxide
BBX060AN9V
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
522-540Informations de copyright
Copyright © 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.